Media headlines about EndoChoice Holdings (NYSE:GI) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. EndoChoice Holdings earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave media stories about the medical equipment provider an impact score of 47.0874919725603 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Shares of EndoChoice Holdings (NYSE GI) remained flat at $8.00 during midday trading on Wednesday. 14,076 shares of the stock were exchanged. EndoChoice Holdings has a 1-year low of $3.64 and a 1-year high of $8.03. The company has a 50 day moving average of $8.00 and a 200 day moving average of $7.14.

WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect EndoChoice Holdings (GI) Share Price” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/04/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-endochoice-holdings-gi-share-price.html.

About EndoChoice Holdings

EndoChoice Holdings, Inc is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Receive News & Stock Ratings for EndoChoice Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EndoChoice Holdings Inc and related stocks with our FREE daily email newsletter.